Published in Mol Cell Proteomics on January 25, 2005
Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. Br J Cancer (2011) 1.32
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl) (2008) 1.16
Endoplasmic reticulum stress or mutation of an EF-hand Ca(2+)-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis. Cell Stress Chaperones (2011) 0.89
Novel translational strategies in colorectal cancer research. World J Gastroenterol (2007) 0.75
Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells. Oncol Lett (2017) 0.75
Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res (2008) 4.20
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol (2009) 2.34
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Evidence-based medicine: the time has come to set standards for staging. J Pathol (2010) 2.26
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics (2008) 2.24
Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology (2002) 2.17
Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study. J Clin Oncol (2011) 2.06
[Educational crisis within gastrointestinal surgery. The solution is not only longer working hours, but also reduced number of younger surgeons-trainees. The condition is centralized emergency surgery]. Ugeskr Laeger (2004) 2.03
Frequent occurrence of uniparental disomy in colorectal cancer. Carcinogenesis (2006) 1.99
Gene expression in colorectal cancer. Cancer Res (2002) 1.98
Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology (2011) 1.86
Sacral nerve stimulation for intractable constipation. Gut (2010) 1.82
A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology (2006) 1.79
Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev (2013) 1.72
Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol (2013) 1.71
SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res (2006) 1.66
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer (2011) 1.65
Low anterior resection syndrome and quality of life: an international multicenter study. Dis Colon Rectum (2014) 1.63
Danish national guidelines for treatment of diverticular disease. Dan Med J (2012) 1.63
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics (2004) 1.57
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Predicting the Risk of Bowel-Related Quality-of-Life Impairment After Restorative Resection for Rectal Cancer: A Multicenter Cross-Sectional Study. Dis Colon Rectum (2016) 1.45
Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer. Cancer Res (2007) 1.45
Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg (2012) 1.41
Pelvic nerve stimulation evokes nitric oxide mediated distal rectal relaxation in pigs. Dis Colon Rectum (2008) 1.41
The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006--a population-based cohort study. Dis Colon Rectum (2009) 1.39
[Danish National Guidelines for diagnostic strategy of patients with colorectal cancer symptoms]. Ugeskr Laeger (2008) 1.39
[Organisation and early outcome of restorative proctocolectomy and ileal pouch-anal anastomosis]. Ugeskr Laeger (2008) 1.39
[Treatment of rectal cancer in Denmark--how can it be improved?]. Ugeskr Laeger (2004) 1.39
Impedance planimetric description of normal rectoanal motility in humans. Dis Colon Rectum (2007) 1.38
Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Cancer Detect Prev (2006) 1.36
Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics (2005) 1.32
Perineal repair after extralevator abdominoperineal excision for low rectal cancer. Dis Colon Rectum (2011) 1.31
Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals. Scand J Gastroenterol (2010) 1.24
Long-term outcome and safety of transanal irrigation for constipation and fecal incontinence. Dis Colon Rectum (2009) 1.22
Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway. Mol Cell Proteomics (2010) 1.22
Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. Br J Haematol (2005) 1.18
Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev (2010) 1.17
Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J Mol Med (Berl) (2008) 1.16
Delay of diagnosis and treatment of colorectal cancer--a population-based Danish study. Cancer Detect Prev (2008) 1.14
Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol (2003) 1.10
MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer (2013) 1.08
Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scand J Gastroenterol (2008) 1.06
Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int J Cancer (2012) 1.06
Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005. Int J Cancer (2010) 1.06
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer. Am J Pathol (2012) 1.04
International validation of the low anterior resection syndrome score. Ann Surg (2014) 1.04
Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. Am J Pathol (2012) 1.03
Identification of differentially expressed genes in keratoconus epithelium analyzed on microarrays. Invest Ophthalmol Vis Sci (2003) 1.00
Gastric transit and small intestinal transit time and motility assessed by a magnet tracking system. BMC Gastroenterol (2011) 1.00
Proteome profiling of corneal epithelium and identification of marker proteins for keratoconus, a pilot study. Exp Eye Res (2005) 0.99
Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort. Mol Oncol (2009) 0.99
Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer. Virchows Arch (2010) 0.98
The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer. BMC Cancer (2012) 0.98
Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer (2012) 0.97
Reproducibility of depth of extramural tumor spread and distance to circumferential resection margin at rectal MRI: enhancement of clinical guidelines for neoadjuvant therapy. AJR Am J Roentgenol (2011) 0.97
Snail1 is over-expressed in prostate cancer. APMIS (2009) 0.96
Gastrointestinal transit in patients with systemic sclerosis. Scand J Gastroenterol (2011) 0.95
Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Cancer (2002) 0.95
Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. Mol Oncol (2007) 0.94
Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis. BMC Genomics (2011) 0.94
Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer. Int J Cancer (2011) 0.94
The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study. Eur J Radiol (2006) 0.93
Six years of experience with sacral nerve stimulation for fecal incontinence. Dis Colon Rectum (2010) 0.92
Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study. BMJ Open (2012) 0.92
Postoperative issues of sacral nerve stimulation for fecal incontinence and constipation: a systematic literature review and treatment guideline. Dis Colon Rectum (2011) 0.91
Major reduction in 30-day mortality after elective colorectal cancer surgery: a nationwide population-based study in Denmark 2001-2011. Ann Surg Oncol (2014) 0.89
Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia. FEBS Lett (2006) 0.89
Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer. Breast Cancer Res Treat (2012) 0.89
Altered expression of CLC, DSG3, EMP3, S100A2, and SLPI in corneal epithelium from keratoconus patients. Cornea (2005) 0.89
Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors. Scand J Gastroenterol (2011) 0.89
Identification of expressed and conserved human noncoding RNAs. RNA (2013) 0.89
15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol Cell Proteomics (2008) 0.88
Clusterin expression in normal mucosa and colorectal cancer. Mol Cell Proteomics (2007) 0.88
High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy. BMC Cancer (2014) 0.88
Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur J Radiol (2007) 0.87
Sacral nerve stimulation for constipation: suboptimal outcome and adverse events. Dis Colon Rectum (2010) 0.87
Bowel dysfunction after rectal cancer treatment: a study comparing the specialist's versus patient's perspective. BMJ Open (2014) 0.86
Evaluation of the Danish national strategy for selective use of colonoscopy in symptomatic outpatients without known risk factors for colorectal cancer. Scand J Gastroenterol (2007) 0.86
Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes (2012) 0.85
Sacral nerve stimulation in fecal incontinence. Dis Colon Rectum (2004) 0.85
Pretreatment HIF-1α and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Res (2011) 0.85
Danish population-based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity. Qual Life Res (2014) 0.85
Bowel function in Danish children with myelomeningocele. APMIS Suppl (2003) 0.84
Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer. Anticancer Res (2012) 0.84
Outcome of transanal irrigation for bowel dysfunction in patients with spinal cord injury. J Spinal Cord Med (2008) 0.84
Rectal volume tolerability and anal pressures in patients with fecal incontinence treated with sacral nerve stimulation. Dis Colon Rectum (2006) 0.84
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol (2007) 0.84
Elevated microRNA-126 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in colorectal cancer. Oncol Lett (2011) 0.84
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. Mol Cell Proteomics (2003) 0.84
Secretagogin is a new neuroendocrine marker in the human prostate. Prostate (2007) 0.84